Anthony Pare
Geen lopende functies
Vermogen: - $ op 30-04-2024
Profiel
Anthony Pare served as the Chief Executive Officer at Bioporto A from 2021 to 2024.
Prior to that, he was the Chief Commercial Officer at Hemanext, Inc. and T2 Biosystems, Inc. He also held the position of VP & General Manager-Global Services at Haemonetics Corp.
In terms of education, he received a graduate degree from George Washington University and an undergraduate degree from Maine Maritime Academy.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BIOPORTO A/S
-.--% | 31-12-2022 | 0 ( -.--% ) | - $ | 30-04-2024 |
Eerdere bekende functies van Anthony Pare
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOPORTO A/S | Algemeen Directeur | 09-01-2024 |
| T2 BIOSYSTEMS, INC. | Corporate Officer/Principal | 08-11-2021 |
Hemanext, Inc.
 Hemanext, Inc. Medical SpecialtiesHealth Technology Hemanext, Inc. develops blood storage systems. Its technology includes anaerobic storage, background on stored blood, science of storage lesion, and clinical implications. The company was founded by Martin A. Cannon and is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
| HAEMONETICS CORPORATION | Corporate Officer/Principal | - |
Opleiding van Anthony Pare
| Maine Maritime Academy | Undergraduate Degree |
| George Washington University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| HAEMONETICS CORPORATION | Health Technology |
| T2 BIOSYSTEMS, INC. | Health Technology |
| BIOPORTO A/S | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Hemanext, Inc.
Hemanext, Inc. Medical SpecialtiesHealth Technology Hemanext, Inc. develops blood storage systems. Its technology includes anaerobic storage, background on stored blood, science of storage lesion, and clinical implications. The company was founded by Martin A. Cannon and is headquartered in Lexington, MA. | Health Technology |
